Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Takashima

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Kekkaku : [Tuberculosis]|July 15, 2006
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy]Tetsuya Takashima, Katsura Danno, Yoshitaka Tamura, et al.
Kekkaku : [Tuberculosis]|November 24, 2004
[Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by line probe assay (LiPA)]Takeshi Higuchi, Takeshi Fushiwaki, Nakako Tanaka, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2007
Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kitSeigo Kitada, Kazuo Kobayashi, Satoshi Ichiyama, et al.
Kekkaku : [Tuberculosis]|January 29, 2009
[Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan]Emiko Toyota, Yoshiko Kawabe, Hideki Yotsumoto, et al.
European Journal of Clinical Pharmacology|November 15, 2012
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapyJunichi Azuma, Masako Ohno, Ryuji Kubota, et al.
Journal of Clinical Microbiology|May 30, 2008
Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in JapanChiyoji Abe, Ikuo Kobayashi, Satoshi Mitarai, et al.
BMC Infectious Diseases|January 25, 2011
Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional studyTakahiro Tabuchi, Toshio Takatorige, Yukio Hirayama, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2004
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigensToru Mori, Mitsunori Sakatani, Fumio Yamagishi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 18, 2016
Turkish and Japanese Mycobacterium tuberculosis sublineages share a remote common ancestorGuislaine Refrégier, Edgar Abadia, Tomoshige Matsumoto, et al.
Kekkaku : [Tuberculosis]|June 15, 2007
[Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid]Satoshi Mitarai, Ikuo Kobayashi, Chiyoji Abe, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Kekkaku : [Tuberculosis]|July 15, 2006
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy]Tetsuya Takashima, Katsura Danno, Yoshitaka Tamura, et al.
Kekkaku : [Tuberculosis]|November 24, 2004
[Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by line probe assay (LiPA)]Takeshi Higuchi, Takeshi Fushiwaki, Nakako Tanaka, et al.
American Journal of Respiratory and Critical Care Medicine|December 15, 2007
Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kitSeigo Kitada, Kazuo Kobayashi, Satoshi Ichiyama, et al.
Kekkaku : [Tuberculosis]|January 29, 2009
[Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan]Emiko Toyota, Yoshiko Kawabe, Hideki Yotsumoto, et al.
European Journal of Clinical Pharmacology|November 15, 2012
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapyJunichi Azuma, Masako Ohno, Ryuji Kubota, et al.
Journal of Clinical Microbiology|May 30, 2008
Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in JapanChiyoji Abe, Ikuo Kobayashi, Satoshi Mitarai, et al.
BMC Infectious Diseases|January 25, 2011
Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional studyTakahiro Tabuchi, Toshio Takatorige, Yukio Hirayama, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2004
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigensToru Mori, Mitsunori Sakatani, Fumio Yamagishi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 18, 2016
Turkish and Japanese Mycobacterium tuberculosis sublineages share a remote common ancestorGuislaine Refrégier, Edgar Abadia, Tomoshige Matsumoto, et al.
Kekkaku : [Tuberculosis]|June 15, 2007
[Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid]Satoshi Mitarai, Ikuo Kobayashi, Chiyoji Abe, et al.
Pageof 2